Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma

SIMPLE SUMMARY: Clinical responses to the initial treatment of high grade serous ovarian cancer (HGSOC) vary greatly. Widespread intra-site and inter-site genomic heterogeneity presents significant challenges for the development of predictive biomarkers based on pre-treatment sampling of select indi...

Descripción completa

Detalles Bibliográficos
Autores principales: Veeraraghavan, Harini, Vargas, Herbert Alberto, Jimenez-Sanchez, Alejandro, Micco, Maura, Mema, Eralda, Lakhman, Yulia, Crispin-Ortuzar, Mireia, Huang, Erich P., Levine, Douglas A., Grisham, Rachel N., Abu-Rustum, Nadeem, Deasy, Joseph O., Snyder, Alexandra, Miller, Martin L., Brenton, James D., Sala, Evis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698381/
https://www.ncbi.nlm.nih.gov/pubmed/33212885
http://dx.doi.org/10.3390/cancers12113403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698381/
https://www.ncbi.nlm.nih.gov/pubmed/33212885
http://dx.doi.org/10.3390/cancers12113403

Ejemplares similares